Search filters

List of works by Andrew P. Catchpole

A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge Model

scientific article

A throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus, influenza A and SARS-CoV

scientific article

Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

scientific article published on 13 January 2016

Alternative base pairs attenuate influenza A virus when introduced into the duplex region of the conserved viral RNA promoter of either the NS or the PA gene.

scientific article published on March 2003

Attenuation of influenza : a virus by base-pair promoter mutations

doctoral thesis by Andrew P. Catchpole

Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

scientific article published on 9 June 2016

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics

scientific article published on 19 June 2024

Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge

scientific article (publication date: 2014)

New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus

scientific article

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

scientific article published on 31 March 2022

The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics.

scientific article

The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process

article published in 2018

Third human challenge trial conference, Oxford, United Kingdom, February 6-7, 2020, a meeting report

scientific article published on 03 June 2020

Use of qualitative integrative cycler PCR (qicPCR) to identify optimal therapeutic dosing time-points in a Respiratory Syncytial Virus Human Viral Challenge Model (hVCM).

scientific article published on 31 August 2015